HD-OPM Archive
Topics › Plaque, CAC & CT angiography

Charles Grashow's protocol to regress coronary calcium over two years

Gokhan Can · Dec 02, 2023 · ♥ 18 reactions · 7 comments · original Facebook post
Plaque, CAC & CT angiographySupplements & vitamins
AI summary & key facts

Describes how Charles Grashow responded to worsening coronary calcium in 2020-2021 with an intensive regimen of lifestyle, high-dose nattokinase, LDL-lowering and anti-inflammatory supplements and off-label drugs. His later scans reportedly showed that the trajectory of his coronary disease had reversed. It is a single-patient story, not a trial.

Charles's Story

When Charles Grashow received concerning test results in 2020 and 2021 showing developing coronary artery disease (CAD), he decided to take action. Over the next two years, Charles implemented an intensive lifestyle, diet, and supplementation regimen aimed at regressing the plaques in his heart's arteries - and it worked. As evidenced by his latest test results, Charles successfully reversed the trajectory of his CAD.

The Start of Charles's Journey

In June 2020, a heart CT scan delivered Charles's first warning, detecting minimal coronary calcification and enlarged pulmonary arteries. While not yet serious, these were early signs of potential issues. By December 2021, a follow-up scan showed Charles's coronary artery calcium score had worsened and now indicated definite, albeit still mild, CAD.

At this point, Charles faced a choice - proceed as usual down the path of advancing atherosclerosis or work diligently to stop and turn back the clock. Motivated by his belief in science and self experimentation, Charles chose the latter.

The Key Components of Charles's Protocol

Charles put together a multi-prong, evidence-based plan attacking CAD from all angles:

Diet - Charles always had a healthy diet.

Exercise & Weight - Though not overweight, Charles always did his weekly cardiovascular exercise and strength training to improve circulatory health.

Supplements & Off Label Drugs - After extensive research Charles introduced various supplements, mostly targeted at lowering LDL particles (“bad” cholesterol), reducing inflammation and oxidative damage, and boosting nitric oxide production for improved vascular function. He followed a general approach to improve his longevity through off label drugs and supplements. He started taking high dose nattokinase (8k FU). Targeted an LDL of 30 mg/dL, and very low inflammation (HS-CRP of 0.5).

The proof is in the plaque - or lack thereof. A June 2023 CT heart scan showed stunning results...

The Payoff: CAD Reversal Documented

An eagerly awaited CT heart scan in June 2023, two and a half years after starting his intensified protocol, brought Charles definitive proof his approach worked.

Some key takeaways:

Simply put, Charles achieved regression of his coronary artery disease - the improved state reflected in his scans confirms this remarkable outcome.

While anecdotal and n=1, Charles’s restoration of cardiovascular wellness illuminates the real potential for nutrition, exercise, select supplements and drugs to favorably influence aging and turn around atherosclerosis.

Charles's Labs (8/2/23)

Lipids:

Liver:

Others:

Since I'm taking high dose Nattokinase I also had my clotting time measured

INR - 1.1 Ref Range 0.9 - 1.2 for non anti-coagulated patients

Prothrombin Time - 11.2 Ref Range 9.1 - 12.0

aPTT - 29 Ref Range 24-33

Charles's Longevity Stack (03/2023)

For cardiovascular/plaque reduction

Lifespan/Healthspan Extension

General Health

##

Coronary Scan Results

  1. June 11, 2020 - CT Heart Structure & Morphology with Contrast
  1. December 6, 2021 - CTA Heart Coronary Arteries & Bypass Graft with Contrast
  1. June 22, 2023 - CTA Heart Coronary Arteries & Bypass Graft with Contrast

Comparative Analysis

#calcium#plaque#supplements#calcifiedplaque#calcification#exercise#cardiovascular#nattokinase
← newer: Dr. Ford Brewer's story: cutting his artery age by 20+ yearsolder: Tom Seest's CAC drop from 66 to 42 over three years, and the →